|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/28 | |
| A61P 17/00 | |||
| A61P 35/00 | |||
| A61P 9/10 | |||
| A61P 31/04 | |||
| A61P 9/00 | |||
| A61P 27/02 | |||
| A61P 7/04 | |||
| A61P 19/02 | |||
| A61P 1/00 | |||
| A61P 17/06 | |||
| A01K 67/027 | |||
| C12N 5/0775 | |||
| A61K 35/12 |
| (11) | Number of the document | 2046349 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07784641.8 |
| Date of filing the European patent application | 2007-07-12 | |
| (97) | Date of publication of the European application | 2009-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2007/000974 |
| Date | 2007-07-12 |
| (87) | Number | WO 2008/006168 |
| Date | 2008-01-17 |
| (30) | Number | Date | Country code |
| 830651 P | 2006-07-12 | US | |
| 830649 P | 2006-07-12 | US |
| (72) |
RAKOCZY, Piroska, Elizabeth, AU
|
| (73) |
Mesoblast, Inc.,
275 Madison Avenue 4th Floor, New York NY 10016,
US
|
| (54) | TREATMENT OF EXCESSIVE NEOVASCULARIZATION |
| TREATMENT OF EXCESSIVE NEOVASCULARIZATION |